论文信息 - Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies - 字舞流文

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies

M. Hidalgo | E. Van Cutsem | H. Hurwitz | C. Verslype | J. Bendell | Chung-Pin Li | F. Dawkins | T. Macarulla | Kenneth H. Yu | E. O’Reilly | C. Walker | Jason Clark | E. Greeno | V. Sahai | A. Sama | Marcelo Adan Garrido Salvo